Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionGreenleaf Trust
Latest Disclosed Ownership20,522 shares
Latest Disclosed Value $ 18,875,520
Greenleaf Trust reports 0.93% decrease in ownership of LLY / Eli Lilly and Company

On April 27, 2026 - Greenleaf Trust filed a 13F-HR form disclosing ownership of 20,522 shares of Eli Lilly and Company (US:LLY) valued at $18,875,520 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 20,715 shares of Eli Lilly and Company. This represents a change in shares of -0.93% during the quarter. The current value of the position is $22,138,723 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Lilly Eli Com 532457108 20,522 -193 -0.93 18,876 -15.21 0.1039
2026-01-21 2025-12-31 13F Lilly Eli Com 532457108 20,715 466 2.30 22,262 44.09 0.2040
2025-10-22 2025-09-30 13F Lilly Eli Com 532457108 20,249 -3,841 -15.94 15,450 -17.73 0.1404
2025-07-17 2025-06-30 13F Lilly Eli Com 532457108 24,090 -2,047 -7.83 18,779 -13.01 0.1660
2025-04-30 2025-03-31 13F Lilly Eli Com 532457108 26,137 70 0.27 21,587 7.27 0.1969
2025-01-24 2024-12-31 13F Lilly Eli COM 532457108 26,067 -2,370 -8.33 20,124 -20.12 0.1832
2024-10-22 2024-09-30 13F Lilly Eli COM 532457108 28,437 505 1.81 25,193 -0.38 0.2241
2024-07-22 2024-06-30 13F Lilly Eli COM 532457108 27,932 1,868 7.17 25,289 24.72 0.2398
2024-04-29 2024-03-31 13F Lilly Eli COM 532457108 26,064 -2,970 -10.23 20,277 19.81 0.1884
2024-01-31 2023-12-31 13F Lilly Eli COM 532457108 29,034 5,210 21.87 16,924 32.26 0.1815
2023-11-09 2023-09-30 13F Lilly Eli COM 532457108 23,824 86 0.36 12,797 14.95 0.1476
2023-08-09 2023-06-30 13F Lilly Eli COM 532457108 23,738 -1,143 -4.59 11,133 30.29 0.1183
2023-05-11 2023-03-31 13F Lilly Eli COM 532457108 24,881 82 0.33 8,545 94,833.33 0.0966
2023-01-25 2022-12-31 13F Lilly Eli COM 532457108 24,799 -43,274 -63.57 9 -99.96 0.1149
2022-11-10 2022-09-30 13F Lilly Eli COM 532457108 68,073 45,191 197.50 22,011 196.68 0.3258
2022-08-12 2022-06-30 13F Lilly Eli COM 532457108 22,882 1,326 6.15 7,419 20.18 0.1123
2022-04-27 2022-03-31 13F Lilly Eli COM 532457108 21,556 966 4.69 6,173 8.55 0.0737
2022-02-11 2021-12-31 13F Lilly Eli COM 532457108 20,590 1,332 6.92 5,687 27.80 0.0667
2021-11-12 2021-09-30 13F Lilly Eli COM 532457108 19,258 231 1.21 4,450 1.90 0.0543
2021-08-10 2021-06-30 13F Lilly Eli COM 532457108 19,027 257 1.37 4,367 24.52 0.0541
2021-04-30 2021-03-31 13F Lilly Eli COM 532457108 18,770 1,925 11.43 3,507 23.31 0.0463
2021-02-08 2020-12-31 13F Lilly Eli COM 532457108 16,845 1,433 9.30 2,844 24.68 0.0378
2020-10-30 2020-09-30 13F Lilly Eli COM 532457108 15,412 -928 -5.68 2,281 -14.98 0.0354
2020-08-12 2020-06-30 13F Lilly Eli COM 532457108 16,340 2,399 17.21 2,683 38.73 0.0470
2020-04-29 2020-03-31 13F Lilly Eli COM 532457108 13,941 1,883 15.62 1,934 22.02 0.0384
2020-02-11 2019-12-31 13F Lilly Eli COM 532457108 12,058 343 2.93 1,585 20.99 0.0248
2019-11-08 2019-09-30 13F Lilly Eli COM 532457108 11,715 -20 -0.17 1,310 0.77 0.0204
2019-07-24 2019-06-30 13F Lilly Eli COM 532457108 11,735 -215 -1.80 1,300 -16.18 0.0206
2019-05-08 2019-03-31 13F Lilly Eli COM 532457108 11,950 548 4.81 1,551 17.59 0.0256
2019-02-07 2018-12-31 13F Lilly Eli COM 532457108 11,402 483 4.42 1,319 12.54 0.0261
2018-10-29 2018-09-30 13F Lilly Eli COM 532457108 10,919 1,104 11.25 1,172 39.86 0.0212
2018-08-07 2018-06-30 13F Lilly Eli COM 532457108 9,815 2,686 37.68 838 51.81 0.0160
2018-04-30 2018-03-31 13F Lilly Eli COM 532457108 7,129 -119 -1.64 552 -9.80 0.0110
2018-02-08 2017-12-31 13F Lilly Eli COM 532457108 7,248 1,102 17.93 612 16.35 0.0124
2017-11-13 2017-09-30 13F Lilly Eli COM 532457108 6,146 1,559 33.99 526 39.15 0.0115
2017-07-24 2017-06-30 13F Lilly Eli COM 532457108 4,587 589 14.73 378 12.50 0.0086
2017-04-28 2017-03-31 13F Lilly Eli COM 532457108 3,998 645 19.24 336 36.03 0.0081
2017-01-24 2016-12-31 13F Lilly Eli COM 532457108 3,353 3,353 247 0.0065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.